Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion type Assertion NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_head.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion description "[LOH of 1p in the heterogeneous population of malignant gliomas may be one of the important factors besides MGMT methylation that predict better outcome in patients treated with TMZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_provenance.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion evidence source_evidence_literature NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_provenance.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion SIO_000772 17721049 NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_provenance.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion wasDerivedFrom lhgdn-20090331 NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_provenance.
- NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_assertion wasGeneratedBy ECO_0000203 NP179966.RAxGcOTd89QL5_mNVMurVK2kJmZsyanJdRXhBTD9zQIPc130_provenance.